NCT03870243View on ClinicalTrials.gov

Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia

NACompletedINTERVENTIONAL

Enrollment

1,240

Participants

Timeline

Start Date

September 2, 2019

Primary Completion Date

July 27, 2022

Study Completion Date

July 27, 2022

Conditions

Severe Pneumonia

Interventions

DEVICE

Bubble CPAP

To see the effectiveness of Bubble Continuous Positive Airway Pressure (bCPAP) in children with severe pneumonia

DEVICE

Low flow oxygen

To see the effectiveness of low flow oxygen in children with severe pneumonia

Trial Locations (1)

1212

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka

All Listed Sponsors

collaborator

Armauer Hansen Research Institute (AHRI), Ethiopia

UNKNOWN

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT03870243 - Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia | Biotech Hunter | Biotech Hunter